7 completed. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers 5 mg Apixaban Oral Dissolving Film (fasting), 5 mg Apixaban Oral Dissolving Film (fed), 5 mg Apixaban Oral Tablet (US RS/RLD) - Random Allocation, Intermittent Fasting | Phase 2 | Completed | TAHO Pharmaceuticals Ltd. | 60 | 2024-11-16 | 2025-04-11 |
| Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting Esomeprazole, Placebo - Dyspepsia | Phase 1 / Phase 2 | Completed | University of Monastir | 500 | 2020-01-20 | 2025-02-25 |
| HRZE Fasted/Fed in Newly Diagnosed TB intravenous administration of 1st line TB drugs, day 1 - Tuberculosis | Phase 2 | Completed | University Medical Center Groningen | 20 | 2013-07-01 | 2015-04-08 |
| Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein Carbohydrate plus whey protein enriched drink - Peptic Ulcer, Gastritis | Phase 2 / Phase 3 | Completed | Federal University of Mato Grosso | 30 | 2013-02-01 | 2013-04-10 |
| Bioavailability Study of Propranolol Under Fasting Conditions Propranolol, Inderal-LA - To Determine Bioequivalence Under Fasting Conditions | Phase 2 | Completed | Par Pharmaceutical, Inc. | 48 | 2005-05-01 | 2008-04-04 |
| Rapid Antidepressant Effects of Yohimbine in Major Depression Yohimbine hydrochloride, Placebo - Depression, Involutional, Major Depresssion | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 11 | 2004-03-01 | 2019-08-29 |
| Role of Leptin in the Neuroendocrine and Immune Response to Fasting r-metHuLeptin, placebo - Fasting | Phase 1 / Phase 2 | Completed | Beth Israel Deaconess Medical Center | 13 | 2002-10-01 | 2017-06-07 |
Depression (1) · Depressive Disorder, Major (1) · Dyspepsia (1) · Gastritis (1) · Intermittent Fasting (1) · Lecithin Cholesterol Acyltransferase Deficiency (1) · Mood Disorders (1) · Peptic Ulcer (1) · Sleep Deprivation (1) · Tuberculosis (1)
Behavior (7) · Feeding Behavior (7) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Behavioral Symptoms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Depressive Disorder (1) · Digestive System Diseases (1) · Duodenal Diseases (1) · Dyslipidemias (1) · Dyssomnias (1)
Carbohydrates (1) · Esomeprazole (1) · Propranolol (1) · Yohimbine (1) · apixaban (1) · metreleptin (1) · recombinant methionyl human leptin (1)
Beth Israel Deaconess Medical Center (1) · Federal University of Mato Grosso (1) · National Institute of Mental Health (NIMH) (1) · Par Pharmaceutical, Inc. (1) · TAHO Pharmaceuticals Ltd. (1) · University Medical Center Groningen (1) · University of Monastir (1)
United States (3) · Brazil (1) · Canada (1) · Indonesia (1) · Tunisia (1)
Carlos A Zarate, M.D. (1) · Christos S Mantzoros, MD, DSc (1) · Denis Audet (1) · Semir Nouira, Professor (1) · Tiffany A Bradley, MD (1)
PMID 21704134, PMID 21917874, PMID 23193213, PMID 25540981, PMID 26661397, PMID 30997650, PMID 33051459, PMID 35820631, PMID 39097160, PMID 41120363
M01RR001032 (1), R01DK058785 (1)